IFNγ Helps CBLB-Deficient CD8+ T Cells to Put Up Resistance to Tregs.
Journal
Cancer immunology research
ISSN: 2326-6074
Titre abrégé: Cancer Immunol Res
Pays: United States
ID NLM: 101614637
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
entrez:
1
4
2022
pubmed:
2
4
2022
medline:
5
4
2022
Statut:
ppublish
Résumé
In this issue, Han and colleagues demonstrate in preclinical cancer models that genetic deletion of the E3 ubiquitin ligase Cbl proto-oncogene B (CBLB) in adoptively transferred CD8+ T cells induces resistance to regulatory T cells. CBLB deletion induces IFNγ and downmodulates TGFβ/SMAD signaling. This ultimately enforces these cells to be way more effective against various cancers. See related article by Han et al., p. 437 (4).
Identifiants
pubmed: 35362047
pii: 689537
doi: 10.1158/2326-6066.CIR-22-0080
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
Interferon-gamma
82115-62-6
Proto-Oncogene Proteins c-cbl
EC 2.3.2.27
Ubiquitin-Protein Ligases
EC 2.3.2.27
Banques de données
ClinicalTrials.gov
['NCT05107674', 'NCT03087591']
Types de publication
Editorial
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
370Commentaires et corrections
Type : CommentOn
Informations de copyright
©2022 American Association for Cancer Research.